bluebird bio (BLUE) Misses Q3 EPS by 11c

bluebird bio (NASDAQ: BLUE) reported Q3 EPS of ($0.61), $0.11 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $6.2 million.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• AeroVironment restates quarterly financials, citing $89M goodwill error